| Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort M Schoettler, LE Lehmann, S Margossian, M Lee, LS Kean, PC Kao, ... Blood Advances 4 (11), 2536-2547, 2020 | 34 | 2020 |
| Race disparities in proton radiotherapy use for cancer treatment in patients enrolled in children’s oncology group trials DS Bitterman, K Bona, F Laurie, PC Kao, SA Terezakis, WB London, ... JAMA oncology 6 (9), 1465-1468, 2020 | 28 | 2020 |
| A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma KD Wright, X Yao, WB London, PC Kao, L Gore, S Hunger, R Geyer, ... Pediatric blood & cancer 68 (2), e28787, 2021 | 23 | 2021 |
| Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer AJ Church, LB Corson, PC Kao, A Imamovic-Tuco, D Reidy, D Doan, ... Nature medicine 28 (8), 1581-1589, 2022 | 20 | 2022 |
| Symptoms and suffering at end of life for children with complex chronic conditions KL Marcus, PC Kao, C Ma, J Wolfe, DD DeCourcey Journal of Pain and Symptom Management 63 (1), 88-97, 2022 | 18 | 2022 |
| MR imaging correlates for molecular and mutational analyses in children with diffuse intrinsic pontine glioma C Jaimes, S Vajapeyam, D Brown, PC Kao, C Ma, L Greenspan, N Gupta, ... American Journal of Neuroradiology 41 (5), 874-881, 2020 | 18 | 2020 |
| A retrospective multicenter study of fatal pediatric melanoma EB Hawryluk, D Moustafa, D Bartenstein, M Brahmbhatt, K Cordoro, ... Journal of the American Academy of Dermatology 83 (5), 1274-1281, 2020 | 17 | 2020 |
| Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma … K Campbell, PC Kao, A Naranjo, T Kamijo, R Ramanujachar, WB London, ... Pediatric Blood & Cancer 70 (2), e30054, 2023 | 10 | 2023 |
| Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma DS Shulman, P Merriam, E Choy, LM Guenther, KL Cavanaugh, PC Kao, ... Cancer Medicine 12 (14), 15207-15216, 2023 | 7 | 2023 |
| Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12-to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification HG Bender, MS Irwin, MD Hogarty, R Castleberry, JM Maris, PC Kao, ... Journal of Clinical Oncology 41 (17), 3149-3159, 2023 | 6 | 2023 |
| Prevalence and Predictors of Iron Deficiency in Adolescent and Young Adult Outpatients: Implications for Screening R Eiduson, MM Heeney, PC Kao, WB London, MD Fleming, LA Shrier Clinical pediatrics 61 (1), 66-75, 2022 | 6 | 2022 |
| PNOC014: Phase IB study results of DAY101 (tovorafenib) for children with low-grade gliomas (LGGs) and other RAS/RAF/MEK/ERK pathway-activated tumors K Wright, C Kline, M Abdelbaki, D Ebb, E Sayour, J Elster, S Leary, ... NEURO-ONCOLOGY 24, 84-84, 2022 | 5 | 2022 |
| Phase II trial of olaparib in combination with ceralasertib in patients with recurrent osteosarcoma. SJ Forrest, MD Kinnaman, JA Livingston, KT Vo, P Merriam, C Clinton, ... Journal of Clinical Oncology 39 (15_suppl), TPS11575-TPS11575, 2021 | 5 | 2021 |
| Phase I multicenter trial of CUDC-907 in children and young adults with relapsed/refractory solid tumors, CNS tumors, and lymphomas. DS Shulman, C Carlowicz, C Gustafson, KT Vo, E Fox, JA Muscal, ... Journal of Clinical Oncology 36 (15_suppl), 10542-10542, 2018 | 5 | 2018 |
| Induction of fetal hemoglobin and reduction of clinical manifestations in patients with severe sickle cell disease treated with shmir-based lentiviral gene therapy for post … EB Esrick, A Federico, D Abriss, M Armant, K Boardman, C Brendel, ... Blood 140 (Supplement 1), 10665-10667, 2022 | 4 | 2022 |
| Phase II study of nivolumab and ipilimumab in children and young adults with INI1-negative cancers. SJ Forrest, J Yi, C Kline, T Cash, AT Reddy, GM Cote, P Merriam, ... Journal of Clinical Oncology 39 (15_suppl), TPS10055-TPS10055, 2021 | 4 | 2021 |
| Clinical impact of molecular tumor profiling in pediatric, adolescent, and young adult patients with extra-cranial solid malignancies: An interim report from the GAIN/iCat2 study. AJ Church, L Corson, PC Kao, A Imamovic-Tuco, W Kang, NR Pinto, ... Journal of Clinical Oncology 39 (15_suppl), 10005-10005, 2021 | 3 | 2021 |
| Characteristics of nonmelanoma skin cancer in children without identifiable risk factors CS Zhong, CC Coughlin, EB Hawryluk, K Hook, SR Humphrey, L Kruse, ... Journal of the American Academy of Dermatology 84 (5), 1472-1476, 2021 | 3 | 2021 |
| Tolerability of ifosfamide‐containing regimen in patients with high‐risk renal and INI‐1‐deficient tumors CI Wong, DJ Benedetti, PC Kao, C Ma, KJ Marcus, EA Mullen Pediatric Blood & Cancer 70 (8), e30422, 2023 | 2 | 2023 |
| Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma V Rameh, S Vajapeyam, A Ziaei, P Kao, WB London, SJ Baker, J Chiang, ... American Journal of Neuroradiology 44 (7), 833-840, 2023 | 2 | 2023 |
